- Business Model
- B2B
- Website
- elpiscience.com
- Total Funding
- $260.0M
- Last Round
- $105.0M Series CMay 2021
- Rounds
- 4
About
Clinical-stage biopharmaceutical developing innovative immunotherapies for oncology and autoimmune diseases.
Summary
Elpi Science is a Biotech company based in China. It has raised $260.0M in total across 4 rounds, most recently a $105.0M Series C round in May 2021. Investors include Lilly Asia Ventures, Greater Bay Area Homeland Development Fund and Hillhouse Capital.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
May 2021
Sign up to see all 4 rounds
Series A through Series C — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Novel bicyclic peptides and drug conjugates for cancer
Clinical-stage biopharmaceutical company founded in 2015 developing best-in-class cancer therapeu...
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/elpi-science"><img src="https://indexed.vc/api/badge/company/elpi-science" alt="Elpi Science on Indexed.vc" width="260" height="76" /></a>